Description
Founded in 1990, Fareva has grown into a global powerhouse with a presence in 12 countries and more than 40 manufacturing sites. The company specialises in delivering high-quality solutions across the entire product lifecycle, from development to commercial production. Its pharmaceutical division is renowned for expertise in sterile and non-sterile formulations, active pharmaceutical ingredients (APIs), and advanced manufacturing technologies. With a strong focus on innovation, regulatory compliance, and sustainability, Fareva partners with clients worldwide to bring their products to market efficiently and reliably.
Key Products and Services
- Pharmaceutical Manufacturing: Sterile and non-sterile production, including tablets, capsules, ointments, and injectable drugs.
- Active Pharmaceutical Ingredients (APIs): Comprehensive API manufacturing capabilities, adhering to strict regulatory standards.
- Development Services: Formulation development, process optimisation, and analytical support to ensure robust product performance.
- Packaging Solutions: Customisable primary and secondary packaging to meet diverse market needs.
- Specialised Technologies: Expertise in advanced manufacturing techniques, including lyophilisation and high-potency drug production.
Fareva’s dedication to excellence and customer-centric approach has cemented its reputation as a trusted partner for pharmaceutical companies globally. By combining cutting-edge technology, stringent quality assurance, and a commitment to sustainability, Fareva continues to drive innovation and deliver value across the pharmaceutical manufacturing landscape.
Manufacturing Information
Capabilities
- Aerosol
- Ampule
- Analytical Services
- APIs (Active Pharmaceutical Ingredients)
- Asceptic Fill-Finish
- Biologics
- Blister
- Capsule
- Chemistry (CMC)
- Clean in Place / Sterilization in Place (CIP/SIP)
- Clinical Dose
- Clinical Packaging
- Clinical Trial Materials
- Containment
- Contract Development
- Contract Development and Manufacturing (CDMO)
- Contract Packaging
- Controlled Substances
- Creams & Ointments
- Cytotoxic & High Potency Compounds
- Dosage Form Development
- Dose Form
- Drug Delivery Devices
- Drug Development
- Ethical
- Filling
- Fluid Bed Processing
- Formulation Development
- Gels
- Generics
- Granulation
- High Containment Operations
- High Potency
- ICH
- Injectables
- Liquids
- Lyophilization
- Micronization
- Non Sterile Dosage
- Ophthalmics
- Oral Drug Delivery
- OTC
- Packaging
- Packaging Equipment
- Parenterals
- Powders
- Process Analytical Technology (PAT)
- Process Development
- Protein and Peptide
- Regulatory Services
- Samples
- Scale-Up
- Semisolids
- Solid Dosage
- Solutions & Suspensions
- Stability Studies
- Sterile
- Sterile Filling
- Sustained Release
- Syringe
- Tablets
- Topicals
- Unit Dosage
- Vaccines
- Vials
Contact Information
Related Listings

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel

CDMO Live Europe 2027
Experience the future of external manufacturing at CDMO Live Europe
26-27st May 2026, Rotterdam










